#$%^&*AU2020200315A120200206.pdf#####ABSTRACT The present invention provides compositions and methods for inducing tolerance in a human. The invention includes administering a genetically modified T cell expressing a CAR wherein the CAR comprises an antigen binding domain, a transmembrane domain, a costimulatory signalling region, and a CD3 zeta signalling domain.WO 2014/012001 PCT/US2013/050293 1/16 V4p zS CL/ /L /L SU SL SL /CC <;/